Thorax · 1999 · 30 citations · 9 references
MedicineImmunologyInternal MedicineClinical ImmunologyImmunopathologyPulmonologyImmunosuppressionImmunosuppression ManagementImmunosuppressive AgentsImmunosuppressive TherapyPulmonary HypertensionVasodilator TherapyImmunosuppressive Drug TherapyInflammatory SignsPrimary HypertensionPulmonary Arterial PressurePulmonary Artery Pressure MeasurementYoung Women
The case history is described of a young woman who presented with primary pulmonary hypertension and non-specific inflammatory signs. The patient received prolonged immunosuppressive treatment with low dose methotrexate and prednisone without any vasodilator agent. After one year the pulmonary artery pressure fell from a mean value of 47 mm Hg to 30 mm Hg and there was a corresponding clinical response. This case suggests that, in patients with pulmonary hypertension of unknown origin, immunopathogenetic factors should be sought in order to consider the utility of immunosuppressive therapy.
9
Survival in Patients with Primary Pulmonary Hypertension
Gilbert E. D’Alonzo, Robyn J. Barst, Stephen M. Ayres et al. · Annals of Internal Medicine · 1991 · 3.5K citations
Factors that influence the outcome of primary pulmonary hypertension.
A. Rozkovec, P. Montañés‐Rodríguez, C M Oakley · Heart · 1986 · 206 citations · Full text